Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-19T00:04:18.023Z Has data issue: false hasContentIssue false

Advantages and disadvantages of the long-term use of telepsychiatry

Published online by Cambridge University Press:  12 May 2022

S. Kinoshita
Affiliation:
Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan
T. Kishimoto*
Affiliation:
Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan
*
Address for correspondence: T. Kishimoto, MD, PhD, Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, #7F Roppongi Hills North Tower 6-2-31 Roppongi, Minato-ku, Tokyo-to 106-0032, Japan. (Email: tkishimoto@keio.jp)
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The College of Psychiatrists of Ireland

To the Editor,

Evidence regarding the long-term use of telemedicine remains inadequate not only in the field of psychiatry, but in other areas of medicine as well. According to the Health Working Papers published by the OECD in January 2020, the use of telemedicine in countries such as Canada, Australia, and Portugal, where figures on the use of telemedicine have been published, represented about 0.1% to 0.2% of face-to-face care visits (Hashiguchi Reference Hashiguchi2020). Prior to the COVID-19 pandemic, telemedicine was a small component of each country’s healthcare system, even in developed countries. As telemedicine becomes more widespread and reports on its long-term use are expected to increase, the accumulation of further evidence is needed before we can accurately discuss the pros and cons of its long-term use.

Psychiatric disorders commonly have a chronic course, with repeated relapses and flare-ups requiring long-term treatment. A recent study in the United States during the COVID-19 pandemic showed that telemedicine was more often used for existing patients, rather than for first-time patients, and for patients requiring long-term treatment, rather than short-term; these trends were especially true for patients with psychiatric disorders (Cortez et al. Reference Cortez, Mansour, Qato, Stafford and Alexander2021). Therefore, the benefits of telepsychiatry could be substantial if it is used appropriately over the long term.

In many diseases, telemedicine has been shown to be as effective as face-to-face care (Snoswell et al. Reference Snoswell, Chelberg, De Guzman, Haydon, Thomas, Caffery and Smith2021). In the psychiatric field, there is evidence that telepsychiatry may improve treatment adherence in patients with depression, bipolar disorder, and schizophrenia (Basit et al. Reference Basit, Mathews and Kunik2020). Particularly for patients with depression, a recent review reported that telepsychiatry may improve quality-of-life scores and prevent relapses and recurrences (Sharma & Devan Reference Sharma and Devan2021). As such evidence accumulates in the future, it may be possible to establish specific diseases and case presentations for which telepsychiatry should be used more actively for follow-up care.

In addition, low household income and declining income are associated with the prevalence and risk of developing mental disorders (Sareen et al. Reference Sareen, Afifi, McMillan and Asmundson2011). Although the initial hardware cost and the availability of an Internet connection must be considered, telepsychiatry is generally considered to be less expensive and less time-consuming than face-to-face care (Hubley et al. Reference Hubley, Lynch, Schneck, Thomas and Shore2016), and the longer the treatment, the greater the economic benefit to the patient.

On the other hand, when the disadvantages of the long-term use of telepsychiatry are considered, these disadvantages that are also seen in short-term use may become more apparent. For example, the use of telepsychiatry can make it difficult to establish a good rapport (Shore Reference Shore2013). For this reason, the long-term use of telepsychiatry may make it longer to establish a good rapport or may decrease the quality of an established rapport, compared with face-to-face practice. When considering the use of long-term telepsychiatry, the targeting of patients with whom a good rapport has been sufficiently established in face-to-face practice might be advisable.

Nevertheless, telepsychiatry is thought to be an effective means of continuing to deliver medical care to patients with obsessive-compulsive disorder, social withdrawal (e.g. hikikomori), and other conditions that make it difficult for them to go out or use public transportation (Aboujaoude et al. Reference Aboujaoude, Salame and Naim2015; Rooksby et al. Reference Rooksby, Furuhashi and McLeod2020). These patients may welcome the long-term use of telepsychiatry; for these patients, however, exposures such as going out are also considered necessary processes for their treatment (Teo 2016; Tandt et al. Reference Tandt, Van Parys, Leyman, Purdon and Lemmens2021). Hence, telepsychiatry should be combined with face-to-face care in an appropriate manner so that the long-term application of telepsychiatry does not reduce such opportunities.

As mentioned above, both the advantages and the disadvantages of the long-term use of telepsychiatry must be kept in mind. In any case, the use of telepsychiatry in accordance with the wishes of the patient and the patient’s medical condition, while keeping in mind the need to maintain a good rapport, will undoubtedly provide benefits that cannot be obtained by face-to-face treatment alone. In the COVID-19 pandemic, the long-term use of telepsychiatry has become necessary, and primary physicians need to be flexible in using telepsychiatry depending on the situation, rather than strictly limiting its use to target patients and diseases.

Conflict of interest

Authors have no conflicts of interest to disclose.

Financial support

This correspondence received no specific grant from any funding agency, commercial or not-for-profit sectors.

References

Aboujaoude, E, Salame, W, Naim, L (2015). Telemental health: a status update. World Psychiatry 14, 223230.CrossRefGoogle Scholar
Basit, SA, Mathews, N, Kunik, ME (2020). Telemedicine interventions for medication adherence in mental illness: A systematic review. General hospital psychiatry 62, 2836.CrossRefGoogle ScholarPubMed
Cortez, C, Mansour, O, Qato, DM, Stafford, RS, Alexander, GC (2021). Changes in short-term, long-term, and preventive care delivery in US office-based and telemedicine visits during the COVID-19 pandemic. JAMA Health Forum 2, e211529e211529.CrossRefGoogle ScholarPubMed
Hashiguchi, TCO (2020). Bringing health care to the patient: An overview of the use of telemedicine in OECD countries. OECD Health Working Papers 116, (https://doi.org/10.1787/8e56ede7-en) Accessed 10 January 2022.CrossRefGoogle Scholar
Hubley, S, Lynch, SB, Schneck, C, Thomas, M, Shore, J (2016). Review of key telepsychiatry outcomes. World Journal of Psychiatry 6, 269.CrossRefGoogle ScholarPubMed
Rooksby, M, Furuhashi, T, McLeod, HJ (2020). Hikikomori: a hidden mental health need following the COVID-19 pandemic. World Psychiatry 19, 399.CrossRefGoogle ScholarPubMed
Sareen, J, Afifi, TO, McMillan, KA, Asmundson, GJ (2011). Relationship between household income and mental disorders: findings from a population-based longitudinal study. Archives of General Psychiatry 68, 419427.CrossRefGoogle ScholarPubMed
Sharma, G, Devan, K (2021). The effectiveness of telepsychiatry: Thematic review. BJPsych Bulletin 18. doi: 10.1192/bjb.2021.115.Google Scholar
Shore, JH (2013). Telepsychiatry: videoconferencing in the delivery of psychiatric care. American Journal of Psychiatry 170, 256262.CrossRefGoogle ScholarPubMed
Snoswell, CL, Chelberg, G, De Guzman, KR, Haydon, HH, Thomas, EE, Caffery, LJ, Smith, AC (2021). The clinical effectiveness of telehealth: a systematic review of meta-analyses from 2010 to 2019. Journal of Telemedicine and Telecare 1357633X211022907.Google ScholarPubMed
Spaniel, F, Novak, T, Motlova, LB, Capkova, J, Slovakova, A, Trancik, P, et al (2015). Psychiatrist’s adherence: A new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system. Journal of Psychiatric and Mental Health Nursing 22, 811820.CrossRefGoogle Scholar
Tandt, HL, Van Parys, H, Leyman, L, Purdon, C, Lemmens, GM (2021). How are OCD patients and their families coping with the COVID-19 pandemic? A qualitative study. Current Psychology 111. doi: 10.1007/s12144-021-01724-5.Google ScholarPubMed
Teo, AR (2010). A new form of social withdrawal in Japan: a review of Hikikomori. International Journal of Social Psychiatry 56, 178185.CrossRefGoogle ScholarPubMed